Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Equity (2019 - 2025)

Exagen (XGN) has disclosed Return on Equity for 7 consecutive years, with 1.21% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 14.0% year-over-year to 1.21%, compared with a TTM value of 1.21% through Dec 2025, up 14.0%, and an annual FY2025 reading of 1.48%, down 54.0% over the prior year.
  • Return on Equity was 1.21% for Q4 2025 at Exagen, down from 0.97% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.21% in Q2 2021 and bottomed at 1.94% in Q1 2025.
  • Average Return on Equity over 5 years is 0.88%, with a median of 0.96% recorded in 2025.
  • The sharpest move saw Return on Equity rose 27bps in 2024, then crashed -104bps in 2025.
  • Year by year, Return on Equity stood at 0.31% in 2021, then tumbled by -222bps to 0.98% in 2022, then increased by 4bps to 0.94% in 2023, then crashed by -43bps to 1.35% in 2024, then rose by 10bps to 1.21% in 2025.
  • Business Quant data shows Return on Equity for XGN at 1.21% in Q4 2025, 0.97% in Q3 2025, and 1.23% in Q2 2025.